Gene-Environment Interaction Studies in Suicidal Behaviour

Advances in Biological Psychiatry

Volumn 30, Issue , 2015, Pages 63-74

  Mandelli, Laura ^a   Serretti, Alessandro ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84945138738     PISSN: 03787354     EISSN: 16622774     Source Type: Book Series    
DOI: 10.1159/000434737     Document Type: Article

References (78)

1. Borges G, Nock MK, Haro Abad JM, et al: Twelvemonth prevalence of and risk factors for suicide attempts in the World Health Organization World Mental Health Surveys. J Clin Psychiatry 2010; 71: 1617-1628.
2. World Health Organization: Preventing Suicide: A Global Imperative. Luxemburg, WHO, 2014.
3. Harrison PJ, Burnet PW: The 5-HT2A (serotonin2A) receptor gene in the aetiology, pathophysiology and pharmacotherapy of schizophrenia. J Psychopharmacol 1997; 11: 18-20.
4. Brent DA, Mann JJ: Familial pathways to suicidal behavior-understanding and preventing suicide among adolescents. New Engl J Med 2006; 355: 2719-2721.
5. Pedersen NL, Fiske A: Genetic influences on suicide and nonfatal suicidal behavior: Twin study findings. Eur Psychiatry 2010; 25: 264-267.
6. Antypa N, Serretti A, Rujescu D: Serotonergic genes and suicide: A systematic review. Eur Neuropsychopharmacol 2013; 23: 1125-1142.
7. Boulougouris V, Malogiannis I, Lockwood G, et al: Serotonergic modulation of suicidal behaviour: integrating preclinical data with clinical practice and psychotherapy. Exp Brain Res 2013; 230: 605-624.
8. Rujescu D, Thalmeier A, Moeller H-J, et al: Molecular genetic findings in suicidal behavior; what is beyond the serotonergic system? Arch Suicide Res 2007; 11: 17-40.
9. Tsai SJ, Hong CJ, Liou YJ: Recent molecular genetic studies and methodological issues in suicide research. Prog Neuropsychopharmacol Biol Psychiatry 2011; 35: 809-817.
10. Roy A, Sarchiopone M, Carli V: Gene-environment interaction and suicidal behavior. J Psychiatr Pract 2009; 15: 282-288.
11. Saveanu RV, Nemeroff CB: Etiology of depression: genetic and environmental factors. Psychiatr Clin North Am 2012; 35: 51-71.
12. Cooper B: Nature, nurture and mental disorder: old concepts in the new millennium. Br J Psychiatry 2001; 40:s91-s101.
13. Brezo J, Bureau A, Merette C, et al: Differences and similarities in the serotonergic diathesis for suicide attempts and mood disorders: A 22-year longitudinal gene-environment study. Mol Psychiatry 2010; 15: 831-843.
14. Caspi A, Sugden K, Moffitt TE, et al: Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003; 301: 386-389.
15. Gibb BE, McGeary JE, Beevers CG, et al: Serotonin transporter (5-HTTLPR) genotype, childhood abuse, and suicide attempts in adult psychiatric inpatients. Suicide Life Threat Behav 2006; 36: 687-693.
16. Roy A, Hu XZ, Janal MN, et al: Interaction between childhood trauma and serotonin transporter gene variation in suicide. Neuropsychopharmacology 2007; 32: 2046-2052.
17. Peyrot WJ, Middeldorp CM, Jansen R, et al: Strong effects of environmental factors on prevalence and course of major depressive disorder are not moderated by 5-HTTLPR polymorphisms in a large Dutch sample. J Affect Disord 2013; 146: 91-99.
18. Shinozaki G, Romanowicz M, Passov V, et al: State dependent gene-environment interaction: serotonin transporter gene-child abuse interaction associated with suicide attempt history among depressed psychiatric inpatients. J Affect Disord 2013; 147: 373-378.
19. Cicchetti D, Rogosch FA, Sturge-Apple ML: Interactions of child maltreatment and serotonin transporter and monoamine oxidase A polymorphisms: depressive symptomatology among adolescents from low socioeconomic status backgrounds. Dev Psychopathol 2007; 19: 1161-1180.
20. Kim JM, Stewart R, Kim SW, et al: Interactions between a serotonin transporter gene, life events and social support on suicidal ideation in Korean elders. J Affect Disord 2014; 160: 14-20.
21. Zalsman G, Huang YY, Oquendo MA, et al: Association of a triallelic serotonin transporter gene promoter region (5-HTTLPR) polymorphism with stressful life events and severity of depression. Am J Psychiatry 2006; 163: 1588-1593.
22. Coventry WL, James MR, Eaves LJ, et al: Do 5HTTLPR and stress interact in risk for depression and suicidality? Item response analyses of a large sample. Am J Med Genet B Neuropsychiatr Genet 2010; 153B:757-765.
23. Wasserman D, Geijer T, Sokolowski M, et al: The serotonin 1A receptor C(-1019)G polymorphism in relation to suicide attempt. Behav Brain Funct 2006; 2: 14.
24. Murphy TM, Ryan M, Foster T, et al: Risk and protective genetic variants in suicidal behaviour: Association with SLC1A2, SLC1A3, 5-HTR1B and NTRK2 polymorphisms. Behav Brain Funct 2011; 7: 22.
25. Ben-Efraim YJ, Wasserman D, Wasserman J, et al: Family-based study of HTR2A in suicide attempts: observed gene, gene . environment and parent-oforigin associations. Mol Psychiatry 2013; 18: 758-766.
26. Shinozaki G, Romanowicz M, Mrazek DA, et al: HTR2A gene-child abuse interaction and association with a history of suicide attempt among Caucasian depressed psychiatric inpatients. J Affect Disord 2013; 150: 1200-1203.
27. Zhang Y, Zhang C, Yuan G, et al: Effect of tryptophan hydroxylase-2 rs7305115 SNP on suicide attempts risk in major depression. Behav Brain Funct 2010; 6: 49.
28. El Mansari M, Guiard BP, Chernoloz O, et al: Relevance of norepinephrine-dopamine interactions in the treatment of major depressive disorder. CNS Neurosci Ther 2010; 16:e1-e17.
29. Haeffel GJ, Getchell M, Koposov RA, et al: Association between polymorphisms in the dopamine transporter gene and depression: evidence for a gene-environment interaction in a sample of juvenile detainees. Psychol Sci 2008; 19: 62-69.
30. Perroud N, Jaussent I, Guillaume S, et al: COMT but not serotonin-related genes modulates the influence of childhood abuse on anger traits. Genes Brain Behav 2010; 9: 193-202.
31. Owen RT: Glutamatergic approaches in major depressive disorder: focus on ketamine, memantine and riluzole. Drugs Today (Barc) 2012; 48: 469-478.
32. Mohler H: The GABA system in anxiety and depression and its therapeutic potential. Neuropharmacology 2012; 62: 42-53.
33. Esteban S, Garcia-Sevilla JA: Effects induced by cannabinoids on monoaminergic systems in the brain and their implications for psychiatric disorders. Progr Neuropsychopharmacol Biol Psychiatry 2012; 38: 78-87.
34. Sokolowski M, Ben-Efraim YJ, Wasserman J, et al: Glutamatergic GRIN2B and polyaminergic ODC1 genes in suicide attempts: Associations and gene-environment interactions with childhood/adolescent physical assault. Mol Psychiatry 2013; 18: 985-992.
35. Claes SJ: CRH, stress, and major depression: A psychobiological interplay. Vitam Horm 2004; 69: 117-150.
36. Bradley RG, Binder EB, Epstein MP, et al: Influence of child abuse on adult depression: moderation by the corticotropin-releasing hormone receptor gene. Arch Gen Psychiatry 2008; 65: 190-200.
37. Grabe HJ, Schwahn C, Appel K, et al: Childhood maltreatment, the corticotropin-releasing hormone receptor gene and adult depression in the general population. Am J Med Genet B Neuropsychiatr Genet 2010; 153B:1483-1493.
38. Heim C, Bradley B, Mletzko TC, et al: Effect of childhood trauma on adult depression and neuroendocrine function: sex-specific moderation by CRH receptor 1 gene. Front Behav Neurosci 2009; 3: 41.
39. Polanczyk G, Caspi A, Williams B, et al: Protective effect of CRHR1 gene variants on the development of adult depression following childhood maltreatment: replication and extension. Arch Gen Psychiatry 2009; 66: 978-985.
40. Ressler KJ, Bradley B, Mercer KB, et al: Polymorphisms in CRHR1 and the serotonin transporter loci: gene . gene . environment interactions on depressive symptoms. Am J Med Genet B Neuropsychiatr Genet 2010; 153B:812-824.
41. Roy A, Hodgkinson CA, Deluca V, et al: Two HPA axis genes, CRHBP and FKBP5, interact with childhood trauma to increase the risk for suicidal behavior. J Psychiatr Res 2012; 46: 72-79.
42. Wasserman D, Sokolowski M, Rozanov V, et al: The CRHR1 gene: A marker for suicidality in depressed males exposed to low stress. Genes Brain Behav 2008; 7: 14-19.
43. Ben-Efraim YJ, Wasserman D, Wasserman J, et al: Gene-environment interactions between CRHR1 variants and physical assault in suicide attempts. Genes Brain Behav 2011; 10: 663-672.
44. Castren E, Rantamaki T: Role of brain-derived neurotrophic factor in the aetiology of depression: implications for pharmacological treatment. CNS Drugs 2010; 24: 1-7.
45. Aguilera M, Arias B, Wichers M, et al: Early adversity and 5-HTT/BDNF genes: new evidence of geneenvironment interactions on depressive symptoms in a general population. Psychol Med 2009; 39: 1425-1432.
46. Bukh JD, Bock C, Vinberg M, et al: Interaction between genetic polymorphisms and stressful life events in first episode depression. J Affect Disord 2009; 119: 107-115.
47. Chen J, Li X, McGue M: Interacting effect of BDNF Val66Met polymorphism and stressful life events on adolescent depression. Genes Brain Behav 2012; 11: 958-965.
48. Gatt JM, Nemeroff CB, Schofield PR, et al: Early life stress combined with serotonin 3A receptor and brain-derived neurotrophic factor valine 66 to methionine genotypes impacts emotional brain and arousal correlates of risk for depression. Biol Psychiatry 2010; 68: 818-824.
49. Grabe HJ, Schwahn C, Mahler J, et al: Genetic epistasis between the brain-derived neurotrophic factor Val66Met polymorphism and the 5-HTT promoter polymorphism moderates the susceptibility to depressive disorders after childhood abuse. Progr Neuropsychopharmacol Biol Psychiatry 2012; 36: 264-270.
50. Hosang GM, Uher R, Keers R, et al: Stressful life events and the brain-derived neurotrophic factor gene in bipolar disorder. J Affect Disord 2010; 125: 345-349.
51. Juhasz G, Dunham JS, McKie S, et al: The CREB1-BDNF-NTRK2 pathway in depression: multiple gene-cognition-environment interactions. Biol Psychiatry 2011; 69: 762-771.
52. Kaufman J, Yang BZ, Douglas-Palumberi H, et al: Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of depression in children. Biol Psychiatry 2006; 59: 673-680.
53. Lavebratt C, Aberg E, Sjoholm LK, et al: Variations in FKBP5 and BDNF genes are suggestively associated with depression in a Swedish population-based cohort. J Affect Disord 2010; 125: 249-255.
54. Perea CS, Paternina AC, Gomez Y, et al: Negative affectivity moderated by BDNF and stress response. J Affect Disord 2012; 136: 767-774.
55. Quinn CR, Dobson-Stone C, Outhred T, et al: The contribution of BDNF and 5-HTT polymorphisms and early life stress to the heterogeneity of major depressive disorder: A preliminary study. Aust NZ J Psychiatry 2012; 46: 55-63.
56. Wichers M, Kenis G, Jacobs N, et al: The BDNF Val(66)Met . 5-HTTLPR . child adversity interaction and depressive symptoms: An attempt at replication. Am J Med Genet B Neuropsychiatr Genet 2008; 147B:120-123.
57. Yang C, Xu Y, Sun N, et al.: The combined effects of the BDNF and GSK3B genes modulate the relationship between negative life events and major depressive disorder. Brain Res 2010; 1355: 1-6.
58. Bresin K, Sima Finy M, Verona E: Childhood emotional environment and self-injurious behaviors: The moderating role of the BDNF Val66Met polymorphism. J Affect Disord 2013; 150: 594-600.
59. Perroud N, Courtet P, Vincze I, et al: Interaction between BDNF Val66Met and childhood trauma on adults violent suicide attempt. Genes Brain Behav 2008; 7: 314-322.
60. Sarchiapone M, Carli V, Roy A, et al: Association of polymorphism (Val66Met) of brain-derived neurotrophic factor with suicide attempts in depressed patients. Neuropsychobiology 2008; 57: 139-145.
61. Dong C, Wong ML, Licinio J: Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: Association with major depression and antidepressant response in Mexican-Americans. Mol Psychiatry 2009; 14: 1105-1118.
62. Perroud N, Aitchison KJ, Uher R, et al: Genetic predictors of increase in suicidal ideation during antidepressant treatment in the GENDEP project. Neuropsychopharmacology 2009; 34: 2517-2528.
63. Pendeville H, Carpino N, Marine JC, et al: The ornithine decarboxylase gene is essential for cell survival during early murine development. Mol Cell Biol 2001; 21: 6549-6558.
64. Leonard B, Maes M: Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neurosci Biobehav Rev 2012; 36: 764-785.
65. Binder EB, Salyakina D, Lichtner P, et al: Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Genet 2004; 36: 1319-1325.
66. Willour VL, Chen H, Toolan J, et al: Family-based association of FKBP5 in bipolar disorder. Mol Psychiatry 2009; 14: 261-268.
67. Roy A, Gorodetsky E, Yuan Q, et al: Interaction of FKBP5, a stress-related gene, with childhood trauma increases the risk for attempting suicide. Neuropsychopharmacology 2010; 35: 1674-1683.
68. Cui H, Nishiguchi N, Ivleva E, et al: Association of RGS2 gene polymorphisms with suicide and increased RGS2 immunoreactivity in the postmortem brain of suicide victims. Neuropsychopharmacology 2008; 33: 1537-1544.
69. Amstadter AB, Koenen KC, Ruggiero KJ, et al: Variation in RGS2 is associated with suicidal ideation in an epidemiological study of adults exposed to the 2004 Florida hurricanes. Arch Suicide Res 2009; 13: 349-357.
70. Ben-Efraim YJ, Wasserman D, Wasserman J, et al: Family-based study of AVPR1B association and interaction with stressful life events on depression and anxiety in suicide attempts. Neuropsychopharmacology 2013; 38: 1504-1511.
71. Kendler KS: Twin studies of psychiatric illness: An update. Arch Gen Psychiatry 2001; 58: 1005-1014.
72. Risch NJ: Mapping genes for psychiatric disorders; in Gershon ES, Cloninger CR (eds): Genetic Approaches to Mental Disorders. Washington, American Psychiatric Press, 1994.
73. Sanders AR, Duan J, Gejman PV: Complexities in psychiatric genetics. Int Rev Psychiatry 2004; 16: 284-293.
74. Brock JF: Nature, nurture, and stress in health and disease. Lancet 1972; 1: 701-704.
75. Laucht M, Treutlein J, Blomeyer D, et al: Interaction between the 5-HTTLPR serotonin transporter polymorphism and environmental adversity for mood and anxiety psychopathology: evidence from a highrisk community sample of young adults. Int J Neuropsychopharmacol 2009; 12: 737-747.
76. Munafo MR, Durrant C, Lewis G, et al: Gene . environment interactions at the serotonin transporter locus. Biol Psychiatry 2009; 65: 211-219.
77. Munafo MR, Flint J: Replication and heterogeneity in gene . environment interaction studies. Int J Neuropsychopharmacol 2009; 12: 727-729.
78. Sullivan PF: Spurious genetic associations. Biol Psychiatry 2007; 61: 1121-1126.